Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 62Rectal Neoplasms 49Breast Neoplasms 48Stomach Neoplasms 37Esophageal Neoplasms 35Colorectal Neoplasms 33Lung Neoplasms 30Squamous Cell Carcinoma of Head and Neck 28Pancreatic Neoplasms 25Brain Neoplasms 25Glioblastoma 23Neoplasms 22Sarcoma 20Neoplasm Metastasis 20Carcinoma, Hepatocellular 18Head and Neck Neoplasms 17Glioma 16Esophageal Squamous Cell Carcinoma 16Colonic Neoplasms 13Recurrence 11Ovarian Neoplasms 10Oropharyngeal Neoplasms 10Melanoma 10Astrocytoma 10Adenocarcinoma Of Esophagus 10Thyroid Neoplasms 9Hypopharyngeal Neoplasms 9Prostatic Neoplasms 8Laryngeal Neoplasms 8Central Nervous System Neoplasms 8

Interventions

sintilimab 1osimertinib 1Surgical Procedures, Operative 1Platinum Compounds 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Resectable Non-small Cell Lung Cancer × Surgical Procedures, Operative × Clear all
NCT07038460 2025-06-26

NEO-LISI

Guangdong Provincial People's Hospital

Phase 2 Not yet recruiting
134 enrolled
Thoracic

Resectable Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡